Accelerating Industrial Strain Engineering through High-Efficiency Polyploid Genome Rewiring. Industrial yeast strains, particularly polyploid Saccharomyces cerevisiae, are the workhorses of global fermentation. However, their complex genomic architecture and high ploidy levels make multi-gene engineering a significant technical bottleneck. CD Biosynsis provides professional Yeast Multi-Gene Knockout Strain Construction Services, utilizing engineered high-copy CRISPR systems and high-throughput mating-based platforms. We enable the simultaneous deactivation of multiple gene targets with up to 100% efficiency, empowering the rapid development of microbial cell factories for biofuels, organic acids, and food safety applications.
Get a Technical QuoteOur platform is optimized for the rigorous demands of industrial biotechnology, offering precise genomic interventions in even the most complex yeast backgrounds. We solve the efficiency challenges inherent in polyploid industrial hosts.
| Service Tier | Technical Strategy | Best For | Standard Deliverables |
|---|---|---|---|
| Polyploid Multi-Knockout | High-copy gRNA CRISPR/Cas9 | Diploid/Triploid industrial strains (e.g., Ethanol Red) | Verified multi-null mutants + Sequencing data |
| HTS Strain Construction | CRI-SPA Mating-based Platform | Rapid metabolic network reconstruction | Large-scale combinatorial mutant libraries |
| Resistance Tuning | Targeted PDR/Drug-pump Deletion | Enhancing toxicity resistance & food safety | Robust model strains for phenotype testing |
| Rapid Fragment Screening | Gene-Specific Knockout Fragments | Shortening development cycles for indel-free edits | High-efficiency engineered clones |
1. Locus Evaluation & Design
2. High-Copy System Assembly
3. Transformation & Mating
4. Industrial Validation
Assessing host ploidy and designing gRNAs to target all alleles across the genome simultaneously.
Formal project proposal and Mutual NDA signing.
Constructing high-copy-number gRNA vectors or generating gene-specific knockout fragments for high penetrance.
Selection of optimized promoters for industrial strain compatibility.
Utilizing direct transformation or the mating-based CRI-SPA platform to introduce editing components.
Parallel processing of multiple gene targets to slash construction timelines.
Verifying metabolic performance (e.g., acid production) and confirming null status across all alleles via WGS.
Final delivery of engineered "cell factory" strains and comprehensive data reports.
To deliver world-class results, our technical team continuously monitors and benchmarks our protocols against landmark research in the field. These studies represent established industrial and academic benchmarks.
Engineering industrial yeast (e.g., diploid and triploid S. cerevisiae) often fails due to low CRISPR plasmid copy numbers. Benchmarks have shown that by utilizing an engineered high-copy gRNA system, researchers achieved 100% efficiency in the simultaneous knockout of four genes (ALD6, PHO13, LEU2, URA3). This system was instrumental in developing industrial strains for lactic acid production from xylose.
(Reference: Lian et al., 2021)
Traditional strain construction is often too slow for modern metabolic network reconstruction. The CRI-SPA platform offers a solution by combining yeast mating with CRISPR-Cas9 technology. This mating-based approach allows for high-throughput, parallel construction of multi-gene knockout strains, significantly shortening the time required to build complex industrial yeast factories.
(Reference: Olsson H.E., 2020)
Meeting safety requirements for commercial food fermentation requires the precise removal of drug-resistance and toxin-pump genes. By successfully targeting and knocking out multiple resistance genes (e.g., pdr5, pdr10, and tpdr15), researchers have built model strains to verify anti-toxicity phenotypes, directly serving the food industry's safety needs.
(Reference: Zhang et al., 2021)
In industrial yeast, relying on simple Indel mutations often leads to tedious screening. Advanced methods for the rapid generation of gene-specific knockout fragments have been developed to bypass these hurdles. This technique significantly accelerates the identification of mutants and improves overall construction efficiency in complex industrial hosts.
(Reference: Dalvie N.C., et al., 2021)
1. Can you handle highly complex polyploid strains like Ethanol Red?
Yes. We specialize in industrial backgrounds. We use high-copy-number gRNA expression systems specifically designed to ensure every allele in a polyploid genome is targeted and deactivated efficiently.
2. What is the maximum number of genes you can knock out in one project?
While it depends on host fitness, we have benchmarks achieving 4-gene knockouts with 100% efficiency in a single round. Using our CRI-SPA mating platform, we can manage even more complex metabolic network rewiring.
3. Do your methods leave antibiotic markers in the final industrial strain?
We offer "clean" markerless engineering options. We utilize transient CRISPR expression or marker-recycle systems to ensure the final strain is suitable for food-grade or industrial regulatory approval.
4. How do you verify that every allele has been knocked out in a polyploid strain?
We perform multi-step validation, including junction PCR to confirm the loss of wild-type alleles across all loci and Whole Genome Sequencing (WGS) to verify the final genetic structure of the triploid or tetraploid host.
5. How does the mating-based CRI-SPA approach save time?
CRI-SPA allows us to bring different genetic components together through yeast mating rather than repeated rounds of transformation. This parallel processing is significantly faster for constructing combinatorial libraries.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.